Outset Medical, Inc.
OM
$4.62
-$0.07-1.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.39% | 23.98% | 36.16% | 46.19% | 35.45% |
| Total Depreciation and Amortization | -38.56% | -37.34% | -27.32% | -21.48% | -11.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.49% | 34.17% | -29.79% | -54.10% | 42.00% |
| Change in Net Operating Assets | 112.08% | -28.26% | 1,553.38% | 161.01% | 18.65% |
| Cash from Operations | 49.95% | 42.25% | 69.27% | 85.53% | 44.10% |
| Capital Expenditure | 47.15% | -418.60% | 59.49% | -143.33% | 65.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.22% | -91.85% | -80.78% | -179.03% | -32.86% |
| Cash from Investing | 110.12% | -92.06% | -81.31% | -180.02% | -32.27% |
| Total Debt Issued | -- | -- | -- | -- | 47.72% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 24.02% | -- | 90.91% | -100.00% | -80.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.10% | 100.00% | 90.91% | -598.70% | -18.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.76% | -101.03% | 31.71% | -739.96% | -32.35% |